<p>The red line traces a score for how well mortality at any given day represents infection estimated by the time-dependent model (refer to axis on the right). The score is given by , where Δ denotes the number of doses in the dataset, () represents the proportion infected in the Wolb<sup>−</sup> (Wolb<sup>+</sup>) group subject to <i>D</i>CV dose <i>j</i>, and () the observed mortality proportion over time in the Wolb<sup>−</sup> (Wolb<sup>+</sup>) group subject to <i>D</i>CV dose <i>j</i>. Gray vertical lines mark the optimal day to measure mortality for dose-response models (day 30, dash-dotted line) and the limits of the acceptable range (days 17 and 46). Dashed lines represent the Gamma distributions that describe old-age mortality, ...
<p><b> values.</b> (A) The time in the outbreak when the strategy should be switched from vaccine-on...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...
<p>Dose-responses models adopted here are the standard formulations (1–3). A,D, Curves represent the...
<p>Parameters with superscripts <sup>−</sup> and <sup>+</sup> relate to Wolb<sup>−</sup> and Wolb<su...
<p>A, Curves represent the estimated dose-response relationships from fitting the model described in...
<p>Fitted Models 1–4 compared with experimental data. In all panels, the log of the dose is on the x...
<p>(A) Mean viremia as a function of the time from symptom onset to sample collection. (B) Mean vire...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 40 treatme...
Survival analysis is a popular area of statistics dealing with time-to-event data. A special charact...
<p>Kaplan-Meier survival curves based on individual animal data show the percent of surviving animal...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 20 treatme...
The relative survival framework is a popular method for the estimation of a subject's survival, corr...
<p>Graph depicts 60-day survival for <i>del/del</i> patients vs. all other patients. P-value stated ...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 20 treatme...
<p><b> values.</b> (A) The time in the outbreak when the strategy should be switched from vaccine-on...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...
<p>Dose-responses models adopted here are the standard formulations (1–3). A,D, Curves represent the...
<p>Parameters with superscripts <sup>−</sup> and <sup>+</sup> relate to Wolb<sup>−</sup> and Wolb<su...
<p>A, Curves represent the estimated dose-response relationships from fitting the model described in...
<p>Fitted Models 1–4 compared with experimental data. In all panels, the log of the dose is on the x...
<p>(A) Mean viremia as a function of the time from symptom onset to sample collection. (B) Mean vire...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 40 treatme...
Survival analysis is a popular area of statistics dealing with time-to-event data. A special charact...
<p>Kaplan-Meier survival curves based on individual animal data show the percent of surviving animal...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 20 treatme...
The relative survival framework is a popular method for the estimation of a subject's survival, corr...
<p>Graph depicts 60-day survival for <i>del/del</i> patients vs. all other patients. P-value stated ...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 20 treatme...
<p><b> values.</b> (A) The time in the outbreak when the strategy should be switched from vaccine-on...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...
Data used for analysis and visualisation of survival curves and hazard ratios for the day 30 treatme...